相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Environmental exposure to asbestos and the risk of lung cancer: a systematic review and meta-analysis
Kyeongmin Kwak et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2022)
Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer
Wei Zhao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
MiRNA identification, characterization and integrated network analysis for flavonoid biosynthesis in Brassicacoraphanus
Libin Zhang et al.
HORTICULTURAL PLANT JOURNAL (2022)
Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers)
Khushwant S. Yadav et al.
EXPERT OPINION ON DRUG DELIVERY (2021)
The next tier of EGFR resistance mutations in lung cancer
Hannah L. Tumbrink et al.
ONCOGENE (2021)
Chitosan oligosaccharide modified liposomes enhance lung cancer delivery of paclitaxel
Yun-qiu Miao et al.
ACTA PHARMACOLOGICA SINICA (2021)
Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes
Julia Jimenez-Lopez et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer
Krishan Kumar et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)
A comprehensive review on nanoemulsion as an ophthalmic drug delivery system
Bhavin R. Choradiya et al.
JOURNAL OF MOLECULAR LIQUIDS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Danielle E. Large et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Folic Acid-Conjugated Mesoporous Silica Nanoparticles and MicroRNA-128-3p Combined with Adriamycin Alleviates the Progression of Non-Small Cell Lung Cancer
Zhijun Zhu et al.
JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING (2021)
Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer
Jiefei Peng et al.
BIOMATERIALS SCIENCE (2021)
Novel molecular targets for the treatment of lung cancer
Rafael Rosell et al.
CURRENT OPINION IN ONCOLOGY (2020)
A signature of tumor immune microenvironment genes associated with the prognosis of non-small cell lung cancer
Jia Li et al.
ONCOLOGY REPORTS (2020)
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Raluca Ioana Teleanu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)
Aaron C. Tan
THORACIC CANCER (2020)
Asbestos-Related Lung Cancer: A Hospital-Based Case-Control Study in Indonesia
Anna Suraya et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
The powerful world of antisense oligonucleotides: From bench to bedside
Anais M. Quemener et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy
Manish Kumar et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
Michelle C. Turner et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Polymeric Nanocarriers with Controlled Chain Flexibility Boost mRNA Delivery In Vivo through Enhanced Structural Fastening
Takuya Miyazaki et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Smart nanocarriers for cancer treatment: Clinical impact and safety
Zehuan Liao et al.
NANOIMPACT (2020)
Nano-engineered nerolidol loaded lipid carrier delivery system attenuates cyclophosphamide neurotoxicity - Probable role of NLRP3 inflammasome and caspase-1
Ashif Iqubal et al.
EXPERIMENTAL NEUROLOGY (2020)
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
Arianna Giacomini et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Mohammad Askandar Iqbal et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Parvarish Sharma et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
MicroRNA replacement therapy in cancer
Homa Mollaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Developing TRAIL/TRAIL death receptor-based cancer therapies
Xun Yuan et al.
CANCER AND METASTASIS REVIEWS (2018)
miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
Feng Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Role of miRNAs in lung cancer
Arif Uddin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
Hadeer M. Abdelaziz et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling
Mohammad Rasheduzzaman et al.
LIFE SCIENCES (2018)
A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS-Mutant Colon Cancer Cells
Akira Inoue et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
Virender Kumar et al.
THERANOSTICS (2018)
Development and Characterization of Aerosol Nanoemulsion System Encapsulating Low Water Soluble Quercetin for Lung Cancer Treatment
N. H. Arbain et al.
MATERIALS TODAY-PROCEEDINGS (2018)
Review of Nanoemulsion Formulation and Characterization Techniques
K. Gurpreet et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
MicroRNA-targeted therapeutics for lung cancer treatment
Jing Xue et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
mTORC1 and mTORC2 in cancer and the tumor microenvironment
L. C. Kim et al.
ONCOGENE (2017)
PM2.5-induced alterations of cell cycle associated gene expression in lung cancer cells and rat lung tissues
Hui Zhao et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2017)
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
B. Biswas et al.
INDIAN JOURNAL OF CANCER (2017)
Nanoemulsion: Concepts, development and applications in drug delivery
Yuvraj Singh et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model
Ana Lygia dos Santos Camara et al.
NANOMEDICINE (2017)
Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models
Jing Tian et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
B. Biswas et al.
INDIAN JOURNAL OF CANCER (2017)
Current Landscape of Targeted Therapy in Lung Cancer
Manasi K. Mayekar et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Improved Antitumor Efficacy of Hyaluronic Acid-Complexed Paclitaxel Nanoemulsions in Treating Non-Small Cell Lung Cancer
Joo-Eun Kim et al.
BIOMOLECULES & THERAPEUTICS (2017)
Nanocarriers for microRNA delivery in cancer medicine
I. Fernandez-Pineiro et al.
BIOTECHNOLOGY ADVANCES (2017)
miRNA nanotherapeutics for cancer
Aditya Ganju et al.
DRUG DISCOVERY TODAY (2017)
Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors
Muhammad Shaalan Beg et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment
Joao Conde et al.
NATURE MATERIALS (2016)
Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer
Takanori Miyoshi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Preparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions
Ting-ting Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells
Nobuhiko Nishijima et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Novel nanoemulsion based lipid nanosystems for favorable in vitro and in vivo characteristics of curcumin
Kun Wan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery
Hyunah Cho et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy
Shengpeng Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Functional nanoemulsion-hybrid lipid nanocarriers enhance the bioavailability and anti-cancer activity of lipophilic diferuloylmethane
Lili Sun et al.
NANOTECHNOLOGY (2016)
Effects of tanshinone nanoemulsion and extract on inhibition of lung cancer cells A549
W. D. Lee et al.
NANOTECHNOLOGY (2016)
Clinical Implications of Genomic Discoveries in Lung Cancer
Charles Swanton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
Zhiqiang Ye et al.
ONCOTARGET (2016)
Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo
Zhao Hao et al.
DRUG DELIVERY (2016)
Safety and efficacy of lorlatinib (PF-06463922) from the dose-escalation component of a study in patients with advanced ALK+ or ROS1+non-small cell lung cancer (NSCLC).
Benjamin J. Solomon et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
MRX34, a liposomal miR-34 mimic, in patients with advanced solid tumors: Final dose-escalation results from a first-in-human phase I trial of microRNA therapy.
David S. Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice
Manu Dalela et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
Rammohan Devulapally et al.
ACS NANO (2015)
miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy
Shiqian Gao et al.
ACTA BIOMATERIALIA (2015)
MagRET Nanoparticles: An Iron Oxide Nanocomposite Platform for Gene Silencing from MicroRNAs to Long Noncoding RNAs
E. Lellouche et al.
BIOCONJUGATE CHEMISTRY (2015)
A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA
Tingting Zhang et al.
CANCER LETTERS (2015)
MicroRNAs in cancer therapeutics: from the bench to the bedside
Paloma del C. Monroig-Bosque et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: In vitro and in vivo studies
Kiran Jyoti et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2015)
Curcumin inhibits the invasion of lung cancer cells by modulating the PKCα/Nox-2/ROS/ATF-2/MMP-9 signaling pathway
Zhigang Fan et al.
ONCOLOGY REPORTS (2015)
Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
Alessandro Bertucci et al.
SMALL (2015)
Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells
B. Santos-Carballal et al.
SCIENTIFIC REPORTS (2015)
Adverse Events of Monoclonal Antibodies Used for Cancer Therapy
Mei Guan et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Efficient Delivery of Therapeutic miRNA Nanocapsules for Tumor Suppression
Chaoyong Liu et al.
ADVANCED MATERIALS (2015)
LUNG CANCER IN 2014 Optimizing lung cancer treatment approaches
Rafael Rosell et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Degradable Hyaluronic Acid/Protamine Sulfate Interpolyelectrolyte Complexes as miRNA-Delivery Nanocapsules for Triple-Negative Breast Cancer Therapy
Shihua Wang et al.
ADVANCED HEALTHCARE MATERIALS (2015)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer
Anupama Mittal et al.
BIOMATERIALS (2014)
Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
Xiongwei Deng et al.
BIOMATERIALS (2014)
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer
Hee Kyung Ahn et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Decreased Expression of miR216a Contributes to Non-Small-Cell Lung Cancer Progression
Ren-Tao Wang et al.
CLINICAL CANCER RESEARCH (2014)
Reciprocal Regulation of MicroRNA-122 and c-Myc in Hepatocellular Cancer: Role of E2F1 and Transcription Factor Dimerization Partner 2
Bo Wang et al.
HEPATOLOGY (2014)
Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells
Asli Ekin et al.
JOURNAL OF GENE MEDICINE (2014)
Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts
Shahar Lev-Ari et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Codelivery of Doxorubicin and Paclitaxel by Cross-Linked Multilamellar Liposome Enables Synergistic Antitumor Activity
Yarong Liu et al.
MOLECULAR PHARMACEUTICS (2014)
Combined Magnetic Nanoparticle-based MicroRNA and Hyperthermia Therapy to Enhance Apoptosis in Brain Cancer Cells
Perry T. Yin et al.
SMALL (2014)
The potential clinical applications and prospects of microRNAs in lung cancer
Ying Gao et al.
ONCOTARGETS AND THERAPY (2014)
Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
Haiying Cheng et al.
LUNG CANCER MANAGEMENT (2014)
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles
Qin Lin et al.
BIOMATERIALS (2013)
A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells
Rajib Ghosh et al.
BIOMATERIALS (2013)
Preclinical Rationale for PI3K/Akt/mTOR Pathway Inhibitors as Therapy for Epidermal Growth Factor Receptor Inhibitor-Resistant Non-Small-Cell Lung Cancer
Shirish M. Gadgeel et al.
CLINICAL LUNG CANCER (2013)
Nanoemulsion loaded with lycobetaine-oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activity
Hui Zhao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Nanoparticle-Based Drug Delivery for Therapy of Lung Cancer: Progress and Challenges
Anish Babu et al.
JOURNAL OF NANOMATERIALS (2013)
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Yun Wu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Epigenetic alteration and microRNA dysregulation in cancer
Hiromu Suzuki et al.
Frontiers in Genetics (2013)
Treatment of lung cancer via telomerase inhibition: Self-assembled nanoplexes versus polymeric nanoparticles as vectors for 2′-O-Methyl-RNA
N. Nafee et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Yong Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Polymeric Nanoparticles Containing Taxanes Enhance Chemoradiotherapeutic Efficacy in Non-small Cell Lung Cancer
Joohee Jung et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Discovering the first microRNA-targeted drug
Morten Lindow et al.
JOURNAL OF CELL BIOLOGY (2012)
Vandetanib Versus Placebo in Patients With Advanced Non-Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized, Double-Blind Phase III Trial (ZEPHYR)
Jin Soo Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial
Cesare Gridelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma
Guang-Yuh Chiou et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou
JOURNAL OF THORACIC ONCOLOGY (2012)
Molecular pathology of lung cancer: key to personalized medicine
Liang Cheng et al.
MODERN PATHOLOGY (2012)
Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial
Li Zhang et al.
LANCET ONCOLOGY (2012)
Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study
Tudor Ciuleanu et al.
LANCET ONCOLOGY (2012)
EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study
Robert Pirker et al.
LANCET ONCOLOGY (2012)
Polymer Nanoparticle-Mediated Delivery of MicroRNA Inhibition and Alternative Splicing
Christopher J. Cheng et al.
MOLECULAR PHARMACEUTICS (2012)
Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo
V. J. Craig et al.
LEUKEMIA (2012)
Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell Carcinoma
Longzhu Piao et al.
MOLECULAR THERAPY (2012)
Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
Amanda Tivnan et al.
PLOS ONE (2012)
Solid Lipid Nanoparticles Loaded with Anti-microRNA Oligonucleotides (AMOs) for Suppression of MicroRNA-21 Functions in Human Lung Cancer Cells
San-Jun Shi et al.
PHARMACEUTICAL RESEARCH (2012)
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
Hai Wang et al.
BIOMATERIALS (2011)
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ahmed Fawzy Ibrahim et al.
CANCER RESEARCH (2011)
Lomustine Loaded Chitosan Nanoparticles: Characterization and in-Vitro Cytotoxicity on Human Lung Cancer Cell Line L132
Archana Mehrotra et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2011)
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial
Roy S. Herbst et al.
LANCET (2011)
MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy
Yun Wu et al.
MOLECULAR PHARMACEUTICS (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
Yu Ren et al.
BMC CANCER (2010)
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Jason F. Wiggins et al.
CANCER RESEARCH (2010)
The miR-34 family in cancer and apoptosis
H. Hermeking
CELL DEATH AND DIFFERENTIATION (2010)
Secondary cytotoxicity mediated by alveolar macrophages: A contribution to the total efficacy of nanoparticles in lung cancer therapy?
Kamal M. H. D. Al-Hallak et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Micro- and nanocarrier-mediated lung targeting
Balak D. Kurmi et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
MicroRNAs as therapeutic targets for lung cancer
William C. S. Cho
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer
Nasser Altorki et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes
Sharif Hossain et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Regression of murine lung tumors by the let-7 microRNA
P. Trang et al.
ONCOGENE (2010)
Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance
Olga B. Garbuzenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lung cancer therapeutics that target signaling pathways: an update
M Roshni Ray et al.
Expert Review of Respiratory Medicine (2010)
Reactive oxygen species-mediated kinase activation by dihydrotanshinone in tanshinones-induced apoptosis in HepG2 cells
Wayne Y. W. Lee et al.
CANCER LETTERS (2009)
Preclinical and clinical studies of anticancer agent-incorporating polymer micelles
Yasuhiro Matsumura et al.
CANCER SCIENCE (2009)
Pathogenesis of lung cancer signalling pathways: roadmap for therapies
E. Brambilla et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
MicroRNA in the immune system, microRNA as an immune system
Li-Fan Lu et al.
IMMUNOLOGY (2009)
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL
Martin Reck et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evaluation of EGFR abnormalities in patients with pulmonary adenocarcinoma: the need to test neoplasms with more than one method
Ruta Gupta et al.
MODERN PATHOLOGY (2009)
Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer
R. Rosell et al.
ANNALS OF ONCOLOGY (2008)
Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles:: Preparation, freeze-drying, and in vitro release
Zhuo Li Yang et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
A microRNA DNA methylation signature for human cancer metastasis
Amaia Lujambio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
D. -W. Kim et al.
ANNALS OF ONCOLOGY (2007)
Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein
Francesco Fazi et al.
CANCER CELL (2007)
Genetic polymorphisms and treatment response in advanced non-small cell lung cancer
Dan Su et al.
LUNG CANCER (2007)
Optimized cationic lipid-based gene delivery reagents for use in developing vertebrate embryos
Michael deCastro et al.
DEVELOPMENTAL DYNAMICS (2006)
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Yoshimasa Saito et al.
CANCER CELL (2006)
Small cell lung cancer: Treatment review
S Cooper et al.
RESPIROLOGY (2006)
let-7 microRNA functions as a potential growth suppressor in human colon cancer cells
Yukihiro Akao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors
J Tsurutani et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-circulating DNA-complexed biodegradable multiblock copolymers for gene delivery:: degradation profiles and evidence of dysopsonization
M Bikram et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
N Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLC
CJ Langer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Apoptosis and lung cancer: A review
N Shivapurkar et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
分享论文
